Genoks began its activities as an R&D laboratory in 2008 and has done many scientific researches on national and international platforms. Genoks and BGI (the world's largest genome Institute) accepted making technology transfer and runs NIPT test, NIFTY, for the first time in Turkey using Next Generation Sequencing Technology. Genoks aims providing technical and strategic support to both private and public health institutes to expand the clinical genetic testing market with own technology background and to maintain its effectiveness in especially neighborhood countries aims to grow in short term with the investments that are to be invested to the hospitals and institutions which seek support in genetic field. Genoks has great sequencing technology could serve as a real high-throughput NGS machine in the assessment of genetics interpretation while huge amount of genome data is produced to contribute to healtcare providers and experts in the field. We are also proud to announce our products GenoXome & GenoMEseq which are affordable for patients. Genoks, furthermore, provides cost-effective NGS solutions such as RNA-seq Transcriptome, miRNA, Animal & Plant Whole Genome Sequencing, etc for research based projects.